COVID-19 ANTIGEN CLINICAL TRIAL IN COLOMBIA

The government of Columbia has recently performed a clinical evaluation of the Edinburgh Genetics ActivXpress+ COVID-19 Antigen Complete Testing Kit with a sample size of over 140 samples. Results show a sensitivity of 90.60% and specificity of 100%. 

​

‘Since September when we started mass manufacturing of COVID-19 antigen tests, we have supplied the tests to governments, hospitals, clinics and employers around the world. Rapid tests have proven to be a useful tool for decision-making by professionals in various settings. We are grateful for the work our local partners have done to improve local access to high-quality diagnostic products. The positive results from the clinical evaluation reflect our commitment to quality and we hope to continue to expand the reach of our reliable and cost-effective products in Latin America and globally.’

Jason Chan, Edinburgh Genetics